Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
topic_facet:"Breast Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (1.788)
1
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer : I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer : A Phase III Open-label, Multicenter, Randomized Trial of Adjuvant Palbociclib in Combination With Endocrine Therapy Versus Endocrine Therapy Alone for Patients With Hormone Receptor Positive / HER2-negative Resected Isolated Locoregional Recurrence of Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Peer Support For Young Adult Women With High Breast Cancer Risk : Peer Support For Young Adult Women With High Breast Cancer Risk
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies : Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors : A Phase 1/2 Open-Label Study of Sacituzumab Govitecan in Japanese Patients With Advanced Solid Tumors (ASCENT-J02)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer : A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
(VELA) Study of BLU-222 in Advanced Solid Tumors : A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management : Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management. The MINERVA Trial - A Phase IV Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 : A Phase Ib Study With a Safety lead-in Cohort and Expansion Phase, of the Safety, Tolerability, Biological Effect, and Efficacy of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers : A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With Pembrolizumab in Patients With Select Advanced Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[179]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Recruiting
Filter aufheben
Thema: Breast Neoplasms
Medienart
1.788
Aufsätze
1.788
E-Artikel
1.788
E-Ressourcen
Zeitschriftentitel
1.788
ClinicalTrials.gov
Thema
1.788
610
Breast Neoplasms
Recruitment Status: Recruiting
1.788
Study Type: Interventional
498
Phase: Phase 2
224
Triple Negative Breast Neoplasms
211
Phase: Phase 3
148
Phase: Phase 1
133
Medical Condition: Breast Cancer
131
Carcinoma
130
Phase: Phase 1, Phase 2
94
Neoplasms
48
Neoplasm Metastasis
44
Brain Neoplasms
44
Phase: Phase 4
36
Lymphedema
34
Breast Carcinoma In Situ
34
Ovarian Neoplasms
30
Breast Cancer Lymphedema
28
Endometrial Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.711
2020-
77
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.788
Englisch
Haven't found what you're looking for?
Wird geladen...